AL
NKTR icon

AJO LP’s Nektar Therapeutics NKTR Stock Holding History

AJO LP’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-855
Closed -$782K – 688
2018
Q3 		$782K Buy
855
+81
+10% +$69.1K ﹤0.01% 543
2018
Q2 		$567K Sell
774
-14
-2% -$16.1K ﹤0.01% 573
2018
Q1 		$1.26M Sell
788
-36
-4% -$46.4K 0.01% 490
2017
Q4 		$738K Buy
+824
New +$487K ﹤0.01% 522

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AJO LP's NKTR Position: Q4 2018 in Review

AJO LP sold out of Nektar Therapeutics (NKTR) in Q4 2018, closing a stake of 855 shares — an estimated $782K sold.

AJO LP first reported a position in NKTR in Q4 2017 and held it in 4 quarters. The position peaked at $1.26M in Q1 2018. 342 funds tracked by Wall St. Rank hold NKTR as of Q4 2018.

  • AJO LP reported no remaining Nektar Therapeutics position as of Q4 2018 after selling out during the quarter.
  • AJO LP sold 855 Nektar Therapeutics shares in Q4 2018, an estimated $782K.
  • AJO LP first reported a position in Nektar Therapeutics in Q4 2017 and held it in 4 quarters.
  • AJO LP's Nektar Therapeutics position peaked at $1.26M in Q1 2018.
  • 342 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2018.

Based on AJO LP's 13F filing for Q4 2018, filed 13 Feb 2019.